Effects of smoked marijuana in healthy and HIV + marijuana smokers
- PMID: 12412834
- DOI: 10.1002/j.1552-4604.2002.tb06001.x
Effects of smoked marijuana in healthy and HIV + marijuana smokers
Abstract
This article presents data from two avenues of marijuana research. First, the author shows that daily marijuana smoking in healthy individuals produces dependence, as demonstrated by withdrawal symptoms such as increased irritability and depression and decreased food intake. In addition, two antidepressant medications were evaluated to assess their potential effectiveness in the treatment of marijuana withdrawal symptoms: (1) sustained-release bupropion (0, 300 mg/day) and (2) nefazodone (0, 450 mg/day). Research participants were regular marijuana smokers who lived in a residential laboratory in groups of two to four. While inpatients, participants smoked active marijuana (2.8%-3.1% THC) repeatedly for 4 days, followed by 8 to 12 days of placebo marijuana (0.0% THC). Results show that during marijuana abstinence, (1) bupropion increased ratings of irritability, depression, and stomach pain and decreased food intake and sleep quality compared to placebo maintenance, and (2) nefazodone decreased anxiety during marijuana withdrawal but did not alter ratings of irritability and misery. Thus, neither medication showed promise as potential treatments for symptoms of marijuana withdrawal. The second avenue of research focused on the effect of cannabinoids in individuals with muscle mass loss, an indicator of wasting in HIV illness. Given that there are little scientific data contributing to the debates concerning medical marijuana, this study directly compared the effects of oral delta9-THC (0, 10, 20, 30 mg PO) to smoked marijuana (0.0%, 1.8%, 2.8%, 3.9% THC) in HIV + marijuana smokers with muscle mass loss (< 90% body cell mass/height). Multiple dimensions of human behavior were measured, including food intake, mood, and cognitive performance. Drugs were administered using a within-subject, double-blind, staggered, double-dummy design. Participants were free to self-select from a variety of foods throughout most of the session. Preliminary data (n = 9) suggest that oral THC was more effective at increasing food intake, but the volunteers "liked" the effects of smoked marijuana more than the effects of oral THC.
Similar articles
-
Marijuana withdrawal in humans: effects of oral THC or divalproex.Neuropsychopharmacology. 2004 Jan;29(1):158-70. doi: 10.1038/sj.npp.1300310. Neuropsychopharmacology. 2004. PMID: 14560320 Clinical Trial.
-
Bupropion SR worsens mood during marijuana withdrawal in humans.Psychopharmacology (Berl). 2001 May;155(2):171-9. doi: 10.1007/s002130000657. Psychopharmacology (Berl). 2001. PMID: 11401006 Clinical Trial.
-
Nefazodone decreases anxiety during marijuana withdrawal in humans.Psychopharmacology (Berl). 2003 Jan;165(2):157-65. doi: 10.1007/s00213-002-1210-3. Epub 2002 Nov 19. Psychopharmacology (Berl). 2003. PMID: 12439626 Clinical Trial.
-
The marijuana withdrawal syndrome: diagnosis and treatment.Curr Psychiatry Rep. 2005 Oct;7(5):360-6. doi: 10.1007/s11920-005-0036-1. Curr Psychiatry Rep. 2005. PMID: 16216154 Review.
-
Marijuana dependence: not just smoke and mirrors.ILAR J. 2011;52(3):295-308. doi: 10.1093/ilar.52.3.295. ILAR J. 2011. PMID: 23382144 Free PMC article. Review.
Cited by
-
Marijuana and body weight.Innov Clin Neurosci. 2014 Jul;11(7-8):50-4. Innov Clin Neurosci. 2014. PMID: 25337447 Free PMC article.
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7. Addict Sci Clin Pract. 2015. PMID: 25896576 Free PMC article. Review.
-
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.Addict Biol. 2008 Jun;13(2):188-95. doi: 10.1111/j.1369-1600.2007.00095.x. Epub 2008 Feb 14. Addict Biol. 2008. PMID: 18279497 Free PMC article. Review.
-
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.Drug Alcohol Depend. 2008 Apr 1;94(1-3):191-8. doi: 10.1016/j.drugalcdep.2007.11.017. Drug Alcohol Depend. 2008. PMID: 18206320 Free PMC article.
-
Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.J Neuroimmune Pharmacol. 2016 Sep;11(3):584-591. doi: 10.1007/s11481-016-9674-9. Epub 2016 Apr 25. J Neuroimmune Pharmacol. 2016. PMID: 27109234 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources